 FLORHAM PARK, N.J., May 17, 2022 GLOBE NEWSWIRE -- Phathom Pharmaceuticals, Inc. Nasdaq: PHAT, an innovative biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, announced today the company will present findings from multiple studies at Digestive Disease Week DDW 2022, being held May 21-24 in person in San Diego, CA and virtually. 